Found: 12
Select item for more details and to access through your institution.
Nilotinib induced bone marrow CD34+/lin–Ph+ cells early clearance in newly diagnosed CP‐chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. E162, doi. 10.1002/ajh.25106
- By:
- Publication type:
- Article
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second‐generation tyrosine kinase inhibitors in the real‐life practice: Identification of risk factors and the role of prophylaxis.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. E159, doi. 10.1002/ajh.25102
- By:
- Publication type:
- Article
Psychological Factors Affecting the Willingness to Accept a Possible Tyrosine Kinase Inhibitor (TKI) Discontinuation in Chronic Myeloid Leukaemia (CML) Patients.
- Published in:
- Patient Preference & Adherence, 2022, v. 16, p. 2963, doi. 10.2147/PPA.S369326
- By:
- Publication type:
- Article
Swine Influenza A(H3N2) Virus Infection in Immunocompromised Man, Italy, 2014.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 6, p. 1, doi. 10.1038/s41408-020-0333-2
- By:
- Publication type:
- Article
Chronic Myeloid Leukemia Patient's Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical Trial.
- Published in:
- Frontiers in Psychology, 2019, p. N.PAG, doi. 10.3389/fpsyg.2019.00329
- By:
- Publication type:
- Article
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 427, doi. 10.1007/s00277-023-05556-0
- By:
- Publication type:
- Article
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- Annals of Hematology, 2019, v. 98, n. 8, p. 1885, doi. 10.1007/s00277-019-03705-y
- By:
- Publication type:
- Article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.
- Published in:
- 2018
- By:
- Publication type:
- journal article